Sector revisions Amgen Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-08-11 EDT			5-day change	1st Jan Change
414.30 ^USD	-0.70%		+6.23%	+26.58%

08-11	Global drugmakers invest billions to boost US presence	RE
08-10	HSBC Adjusts Price Target on Amgen to $445 From $425, Keeps Buy Rating	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	AMGEN INC.							29
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							22
	ABBVIE INC.							28
	ROCHE HOLDING AG							18
	NOVARTIS AG							21
	ASTRAZENECA PLC							22
	NOVO NORDISK A/S							24
	GILEAD SCIENCES, INC.							27
	PFIZER INC.							26
	VERTEX PHARMACEUTICALS INCORPORATED							25
	BRISTOL-MYERS SQUIBB COMPANY							24
	SANOFI							23
	GSK PLC							20
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							16
	BAYER AG							18
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							15
	HALEON PLC							17
	TEVA PHARMACEUTICAL INDUSTRIES LIMITED							10
	Average							21
	Weighted average by Cap.							24